# Taro Pharmaceuticals Inc., Brampton, Canada – FDA Inspections

Source: https://www.keypedia.com/companies/taro-pharmaceuticals-inc/2072a3d5-a0ae-4bb7-9375-a6406a4fd768

> Inspection records and compliance data for Taro Pharmaceuticals Inc. in Brampton. 8 FDA inspections on record, 2 Form 483s, last inspected March 27, 2026.

---

## Details

- Name: Taro Pharmaceuticals Inc.
- FEI Number: 3002808384
- Canada Business Number: 826234262RC0001
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: 130 East Dr
- City: Brampton
- Country Name: Canada
- Address: 130 East Dr, Brampton, Canada
- Country: Canada

## Related Documents

- FDA Inspection 1312804 - Taro Pharmaceuticals Inc. - 2026-03-27 — source: FDA, date: March 27, 2026
- FDA Inspection 1312804 - Taro Pharmaceuticals Inc. - 2026-03-27 — classification: No Action Indicated (NAI), source: FDA, date: March 27, 2026
- Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #87313 - 2025-09-09 — source: Canada, date: September 9, 2025
- Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #86076 - 2025-03-24 — source: Canada, date: March 24, 2025
- Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #86075 - 2025-03-24 — source: Canada, date: March 24, 2025
- Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #86073 - 2025-03-24 — source: Canada, date: March 24, 2025
- FDA Inspection 1257703 - Taro Pharmaceuticals Inc. - 2024-09-20 — source: FDA, date: September 20, 2024
- FDA Inspection 1257703 - Taro Pharmaceuticals Inc. - 2024-09-20 — classification: No Action Indicated (NAI), source: FDA, date: September 20, 2024
- Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #80957 - 2023-05-02 — source: Canada, date: May 2, 2023
- Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #80865 - 2023-05-02 — source: Canada, date: May 2, 2023
- [483 - Taro Pharmaceuticals Inc. - 2022-09-16](https://www.keypedia.com/records/483/taro-pharmaceuticals-inc/bb5cda45-9f89-42a6-9724-d0f098043f78) — source: FDA, date: September 16, 2022
- [FDA Inspection 1180887 - Taro Pharmaceuticals Inc. - 2022-09-16](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/5f06f6fb-7c0a-44ca-8fd5-6aad610d4a0c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 16, 2022
- [Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #78187 - 2022-02-14](https://www.keypedia.com/records/canada_inspection/taro-pharmaceuticals-inc/3098e23a-f098-418a-85fc-d9cdcad0b232) — source: Canada, date: February 14, 2022
- Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #78186 - 2022-02-14 — source: Canada, date: February 14, 2022
- Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #78185 - 2022-02-14 — source: Canada, date: February 14, 2022
- [FDA Inspection 1088553 - Taro Pharmaceuticals Inc. - 2019-05-03](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/6c8456ba-f9bc-45c1-aab9-d88bf456c31a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2019
- Canada Inspection - Taro Pharmaceuticals Inc. - Inspection #71803 - 2019-03-11 — source: Canada, date: March 11, 2019
- [FDA Inspection 1001628 - Taro Pharmaceuticals Inc. - 2017-01-20](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/03164ddc-43fe-4ffd-90c6-1c18d24b8d7d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 20, 2017
- [FDA Inspection 984831 - Taro Pharmaceuticals Inc. - 2016-07-29](https://www.keypedia.com/records/fda_inspections/taro-pharmaceuticals-inc/48a32949-7f77-49a7-b273-e98b9542286a) — classification: No Action Indicated (NAI), source: FDA, date: July 29, 2016
- FDA Inspection 868155 - Taro Pharmaceuticals Inc. - 2014-02-28 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 28, 2014

## Related Companies

- [Pharmascience Inc.](https://www.keypedia.com/companies/pharmascience-inc/2fa6f1e7-a980-4d37-b8d0-daf9e3a309c4)
- [Bausch Health Companies Inc.](https://www.keypedia.com/companies/bausch-health-companies-inc/3190f4ed-695e-491f-a57e-1ef128f7e2af)
- [Halo Pharmaceutical Canada Inc](https://www.keypedia.com/companies/halo-pharmaceutical-canada-inc/1f4cfadf-e895-4fd7-a813-959f505dd7ce)
- [Voyant Beauty, Inc.](https://www.keypedia.com/companies/voyant-beauty-inc/881e2944-36f2-4984-9ca9-319b61788b64)
- [Church & Dwight Canada Corp.](https://www.keypedia.com/companies/church-dwight-canada-corp/cbcb0b61-bee8-4359-88e4-831475253c5b)
- [Patheon Inc.](https://www.keypedia.com/companies/patheon-inc/5aa1b743-e01d-49ef-afca-c234bb7fa32b)
- [Trillium Health Care Products Inc.](https://www.keypedia.com/companies/trillium-health-care-products-inc/e3791250-cb4e-4726-b84b-e9ad526a38c3)
- [Contract Pharmaceuticals Limited Canada](https://www.keypedia.com/companies/contract-pharmaceuticals-limited-canada/02ec2d1f-df8d-4636-95d2-b548aea571d8)
- [Lernapharm (Loris) Inc.](https://www.keypedia.com/companies/lernapharm-loris-inc/2321aaaa-6f7e-4dc9-9c7e-09593fa9efda)
- [Kenvue Canada Inc.](https://www.keypedia.com/companies/kenvue-canada-inc/5ebdb680-6bdf-4d05-887c-3d175e32f038)

## Related Officers

- [investigator](https://www.keypedia.com/people/marian-e-ramirez/4b718b67-fee0-488c-9354-ee366d3510ad)